Mia's Feed
Medical News & Research

Uncovering How Bone Metastasis Causes Anemia Through Cancer's Iron Hijacking

Uncovering How Bone Metastasis Causes Anemia Through Cancer's Iron Hijacking

Share this article

New research reveals how metastatic cancer in bone hijacks iron-recycling cells, leading to anemia and supporting tumor growth. Discover the cellular mechanisms behind this process and potential therapeutic approaches.

2 min read

Researchers from Princeton University have uncovered a cellular mechanism explaining why bone metastasis often results in anemia in cancer patients. The study, published in the journal Cell, reveals that metastatic cancer cells in bone tissue hijack specialized iron-recycling cells, known as erythroblast island (EBI) macrophages. Under healthy conditions, these macrophages support red blood cell development by supplying iron; however, in the presence of cancer, tumor cells manipulate these macrophages, diverting their iron away from developing red blood cells and supporting tumor growth instead.

The research team, led by Yibin Kang and Yujiao Han, found that cancer cells effectively 'commandeer' EBI macrophages, depriving red blood cells of the iron necessary for their maturation, which contributes to anemia. Interestingly, the tumor cells also adapt by producing hemoglobin, mimicking red blood cells, to survive in the oxygen-poor environment of the bone. This process not only sustains the tumor but also creates a cycle of iron theft and red blood cell production disruption.

The study emphasizes the importance of viewing metastasis not only from the perspective of cancer 'seeds' but also by understanding the 'soil'—the surrounding environment that nurtures or inhibits cancer growth, as proposed by the 'seed and soil' hypothesis. Advanced cell-labeling and single-cell sequencing techniques allowed scientists to visualize and map the bone marrow microenvironment, uncovering how cancer cells recruit macrophages to support tumor expansion.

This discovery opens potential new avenues for therapies targeting the tumor's manipulation of iron metabolism in bone metastasis. Such strategies aim to not only slow or halt tumor progression but also to alleviate associated complications like anemia, significantly improving patient quality of life.

In addition to metastatic breast cancer, these findings could apply to other cancers that spread to bone, providing a broader understanding of how tumors interact with their microenvironment. This research underscores the significance of targeting both cancer cells and their supportive niches for more effective treatments.

Source: https://medicalxpress.com/news/2025-09-cancer-iron-theft-uncovers-bone.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Are You Truly Allergic to Penicillin? A Pharmacist Reveals the Truth Behind Common Mislabeling

Many people are incorrectly labeled as allergic to penicillin, which can impact treatment options. Learn how testing can clarify your allergy status and improve healthcare outcomes.

Enhancing Physician Awareness and Screening for Fragile X-Related Conditions

Experts from UC Davis emphasize the urgent need to improve awareness and screening of fragile X-related genetic conditions, including fragile X syndrome and associated disorders, to enable early diagnosis and intervention.

Declining Use of Benzodiazepines Among Older Adults Post-Hospitalization Offers Hope but Risks Persist

Recent studies reveal a decline in benzodiazepine use among older adults post-hospitalization, yet many continue long-term use with associated health risks such as falls and dependence. Preventative strategies are essential to improve safety.